1Resident in Anaesthesia, NHL MMC
2Associate Professor in Anaethesiology, Amcmet, LG Hospital, Ahmedabad
3Professor in Anaesthesiology, NHLMMC, V.S Hospital, Ahmedabad
4Resident Inanaesthesia, NHL MMC
5Resident Inanaesthesia, NHL MMC
6Resident Inanaesthesia, NHL MMC
Online published on 21 September, 2015.
Present study was designed to evaluate Efficacy of two different α2 agonists Clonidine (45 μg) and DXM(5μg) as a adjuvant to intrathecal Hyperbaric Bupivacaine 0.5%.
To Compare the onset of sensory and motor block. Compare the duration of sensory and motor block. Assess the duration of effective postop analgesia. Compare haemodynamic changes. Observe adverse effects.
We have given spinal anaesthesia for lower abdominal & lower limb surgeries with clonidine &DXM as adjuvant.
Both clonidine & DXM delays sensory& motor onset, prolongs duration of sensory& motor analgesia, and postoperative analgesia as compare to Bupivacaine group with minimum haemodynamic changes.
Both clonidine & DXM can be used as adjuvant to bupivacaine for prolonged analgesia.
